Ray First Quarter 2025 Earnings: EPS: ₩160 (vs ₩338 loss in 1Q 2024)

Ray (KOSDAQ:228670) First Quarter 2025 Results

Key Financial Results

• Revenue: ₩24.5b (up 41% from 1Q 2024).
• Net income: ₩2.50b (up from ₩5.17b loss in 1Q 2024).
• Profit margin: 10% (up from net loss in 1Q 2024).
• EPS: ₩160 (up from ₩338 loss in 1Q 2024).

We've discovered 1 warning sign about Ray. View them for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ray Earnings Insights

Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Medical Equipment industry in South Korea.

Performance of the South Korean Medical Equipment industry.

The company's shares are down 2.4% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 1 warning sign for Ray that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.